---
title: Pulmonary Hypertension (PH)
date: "2023-01-22"
enableToc: false
---

> [!info]
>
> ðŸŒ± ä¾†è‡ª: [[Huppert's Notes]]

# Pulmonary Hypertension (PH) #ðŸš§ æ–½å·¥ä¸­

### Pulmonary Hypertension (PH)

â€¢Â Â Â Note: See Cardiology Chapter 1 for additional details

â€¢Â Â Â Classifications of PH: Mneumonic = **AVRT O**ther

-Â Â Â **Group 1**: **A**rterial- Primary PAH. SLE, scleroderma, toxins (methamphetamine, cocaine), HIV

**â€¢**Â Â Â Dx: Utox, ANA, RF, TTE, HIV, hepatitis serologies, LFTs

**â€¢**Â Â Â Tx: PDE5 inhibitor (first line, e.g., sildenafil), endothelin receptor antagonists (second line), prostacyclins (third line, e.g., Flolan), and treat underlying cause. Consider lung transplant referral.

-Â Â Â **Group 2**: **V**enous- Back up from left heart due to cardiac disease (valve disease, cardiomyopathy)

**â€¢**Â Â Â Dx: Right heart cath, TTE

**â€¢**Â Â Â Tx: Diuresis

-Â Â Â **Group 3**: **R**espiratory, due to pulmonary disease- OSA, COPD

**â€¢**Â Â Â Dx: High-resolution chest CT, sleep study, PFTs

**â€¢**Â Â Â Tx: Supplemental oxygen, treat underlying disease

-Â Â Â **Group 4**: **T**hromboembolic disease (i.e., chronic PEs)

**â€¢**Â Â Â Dx: VQ scan (preferred over CT-PE to diagnose chronic PEs)

**â€¢**Â Â Â Tx: Anticoagulation

-Â Â Â **Group 5**: **O**ther: Sarcoid, sickle cell, hemolytic anemia, metabolic disease

